Fortress Biotech, Inc.
FBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001429260
No open-market purchases or sales by Fortress Biotech, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $17.7M in total; no superinvestor holds it.
Other share classesFBIOP
Q1 2025 vs. Q4 2024
How the institutions holding Fortress Biotech, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 53 | 46 | −7 |
| Shares | 4.82M | 4.91M | +94.8K (+2.0%) |
| Value | $9.77M | $7.66M | −$2.11M (−21.6%) |
New holders (2)
Institutions that held Fortress Biotech, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 12,464 | $19.0K | 0.00% |
| Tme Financial, Inc. | 11,500 | $17.9K | 0.02% |
Sold out (9)
Institutions that held Fortress Biotech, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Gsa Capital Partners LLP | 60,474 | $122.0K |
| Susquehanna International Group, LLP | 59,213 | $119.9K |
| Jane Street Group, LLC | 34,159 | $69.2K |
| XTX Topco Ltd | 30,619 | $62.0K |
| Wolverine Trading, LLC | 12,156 | $26.5K |
| Meridian Wealth Management, LLC | 10,000 | $20.3K |
| Tower Research Capital LLC (TRC) | 1,973 | $4.00K |
| R Squared Ltd | 1,380 | $2.79K |
| Marshall & Sterling Wealth Advisors Inc. | 460 | $932 |